Adam Dudum
CEO
Adam Dudum is the co-founder and CEO of Hims & Hers, a telehealth company that has expanded into Canada, aiming to offer generic semaglutide and leverage its U.S. experience in the burgeoning market for diabetes and weight-loss drugs.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
35,223
Power
1,576$
Sentiment
7.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 7.00 | 0.09% | +0% | 38,005,238 | 35,223 | $1,700,000 | 1,576$ |
| Totals | 1 | 38,005,238 | 35,223 | $1,700,000 | 1,576$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Adam Dudum, co-founder and CEO of Hims & Hers, plans to use their experience in Canada to help with international expansion.
7
Evan Seigerman
Per Bank
Khalid Bhatti
Dave Suchon
Farris Smith
Ebele Ola
Mathilde Merlet
Kyle Zien
Brett Belchetz
The Globe and Mail: Canada will be a launching pad for the global race for generic Ozempic